In validating aforementioned genes, using RT-PCR experiment, it was indicated that the patterns of relative gene expression for these genes (LASP1, TUBA1C, and S100A6) were significant between MS cases and controls (P < 0.05). This evidence concerns the gene TUBA1C and myeloid sarcoma.